Inventor · disambiguated record
Rosemarie Mang
Also filed as: MANG ROSEMARIE
6 granted patents·12 pending applications·23 citations·filing 2003–2022
80Inventor score
Files withNabriva Therapeutics GmbH6MANG ROSEMARIE4ASCHER GERD3NABRIVA THERAPEUTICS AG3NABRIVA THERAPEUTICS FORSCHUNG2
Top patents by PatentIndex Score
18 records- 0183US8222447B2Organic compoundsMANG ROSEMARIE·Filed 2009·Granted Jul 17, 2012·9 cites·13 claims
- 0283US8071643B2Pleuromutilin derivatives for the treatment of diseases mediated by microbesMANG ROSEMARIE·Filed 2008·Granted Dec 6, 2011·6 cites·11 claims
- 0380US8153689B2Pleuromutilin derivatives for the treatment of diseases mediated by microbesMANG ROSEMARIE·Filed 2011·Granted Apr 10, 2012·4 cites·5 claims
- 0473US7790767B2Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl groupNABRIVA THERAPEUTICS FORSCHUNG·Filed 2006·Granted Sep 7, 2010·3 cites·10 claims
- 0573US2022218713A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNabriva Therapeutics GmbH·Filed 2022·Application pending·0 cites
- 0671US8088823B2Tuberculosis treatment using pleuromutilin derivativesASCHER GERD·Filed 2007·Granted Jan 3, 2012·1 cites·2 claims
- 0770US2021113571A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNabriva Therapeutics GmbH·Filed 2020·Application pending·0 cites
- 0868US2020281933A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNabriva Therapeutics GmbH·Filed 2020·Application pending·0 cites
- 0964US2020030335A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNabriva Therapeutics GmbH·Filed 2019·Application pending·0 cites
- 1063US2019175603A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNabriva Therapeutics GmbH·Filed 2019·Application pending·0 cites
- 1163US2014256731A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNABRIVA THERAPEUTICS AG·Filed 2014·Application pending·0 cites
- 1261US2018303842A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNabriva Therapeutics GmbH·Filed 2018·Application pending·0 cites
- 1361US2017266194A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNABRIVA THERAPEUTICS AG·Filed 2017·Application pending·0 cites
- 1459US2009118366A1Organic compoundsNABRIVA THERAPEUTICS FORSCHUNG·Filed 2007·Application pending·0 cites
- 1558US2013040954A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesMANG ROSEMARIE·Filed 2012·Application pending·0 cites
- 1654US2012046276A1Tuberculosis treatment using pleuromutilin derivativesASCHER GERD·Filed 2011·Application pending·0 cites
- 1747US2005215637A1Tuberculosis treatmentASCHER GERD·Filed 2003·Application pending·0 cites
- 1844US8343972B2Organic compoundsNABRIVA THERAPEUTICS AG·Filed 2006·Granted Jan 1, 2013·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Rosemarie Mang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →